Clinical Role - Hospital

Pharmacy Times® is at the forefront of providing the latest clinical updates, patient counseling tools and innovative solutions to hospital pharmacists and reaches more than 200,000 pharmacy professionals in total.

Hemophagocytic lymphohistiocytosis (HLH) induced by lamotrigine was recently an active topic on social media, with users following a recent article that reported an Austin, Texas detective had died from the condition in 2018.
Key opinion leaders discuss the importance of HRD testing, with special consideration of tissue testing versus somatic testing.
This medication is the first precision therapy approved to treat a genomically defined population of patients with GIST, according to Blueprint Medicines.
Utilizing a DOAC
Considerations for transitioning patients from heparin over to a direct oral anticoagulant for venous thromboembolism prophylaxis, and strategies that can help health care professionals better manage patients through a drug shortage.
HPV Vaccine
The CDC has reported 34800 new cancer diagnoses linked to HPV annually, and the virus is predicted to account for more than 90% of all cervical and anal cancers, more than 60% of all penile cancers, and 70% of all oral cancers.
revenue integrity
Girish Dighe, PharmD, MS, explains why it's important to understand more than just the revenue integrity piece of the puzzle. 
compounding group
Members of the former International Academy of Compounding Pharmacists voted in November 2019 to change the association’s name to the Alliance for Pharmacy Compounding.
FDA Approval
Deferasirox is indicated for treating chronic iron overload caused by repeated blood transfusions in patients age 2 years and older.
prostate cancer
Since 2004, the FDA has approved different treatments for advanced prostate cancer, adding almost 2-3 indications per year for the past 15 years.
The Prescription Drug User Fee Act date, the FDA action data for this supplemental application, is scheduled for the second quarter of 2020.
insulin aspart injection
The treatment is the first and only fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation, according to Novo Nordisk.
treatment of gout
Novadoz Pharmaceuticals, who markets the product, has commenced shipping of the drug, available in bottles of 30 tablets.